Fas-binding domain of Daxx acts as a dominant-nega-
To determine the tissue distribution of Daxx, we performed a Northern analysis with a Daxx C-terminal tive inhibitor of Fas-induced apoptosis and JNK activation. Furthermore, using dominant-negative and constiprobe. A 2.6 kb transcript, consistent with the length of the open reading frame, was detected in various adult tutively active forms of Daxx and FADD, we show that Fas engages two independent pathways to induce cell mouse tissues ( Figure 2B ). The expression of Daxx appeared uniform, with the exception of stronger expresdeath: one pathway via Daxx that involves JNK activation and is blocked by Bcl-2, and a second pathway via sion in testis. Shorter hybridizing transcripts were also detected in liver, kidney, and testis. Cell lines from many FADD that is Bcl-2 insensitive.
tissues have been reported to support the ability of ectopically expressed Fas to induce apoptosis, suggesting Results that the downstream signaling mechanism is present in most tissues. Similarly, FADD is expressed ubiquitously Two-Hybrid Screen for Novel in adult tissues (Boldin et al., 1995b; Chinnaiyan et al., Fas-Interacting Proteins 1995) . To identify novel Fas-interacting proteins, we performed a two-hybrid screen with the death domain of murine Daxx Interacts with Fas Both In Vitro and In Vivo Fas fused to the DNA-binding protein LexA (LexA- In the two-hybrid system, the Daxx C-terminal region mFasDD). A plasmid library of fusions between a traninteracted strongly with Fas, confirming that Daxx is the scription activation domain and cDNAs from human functional homolog of clone A21 ( Figure 1B ). We then HeLa cells was screened for interaction with LexAtested the binding of full-length murine Daxx protein mFasDD in a yeast reporter strain. One group of positive in vitro and in mammalian cells. In vitro translated, interactors, typified by clone A21, interacted strongly 35 S-labeled Daxx bound to immobilized glutathione with FasDD. However, it interacted poorly with either S-transferase (GST) fusion proteins of Fas death domain Fas-lpr cg , an I224A mutation in the Fas death domain that abrogates Fas signaling and causes lymphoproliferation in mice (reviewed by Nagata, 1997) , or with Fas-FD8, a functionally inactive deletion mutation of the Fas death domain (Figure 1B ). Sequence analysis of clone A21 revealed it to encode a portion of a novel protein.
In the two-hybrid system, clone A21 also interacted with the intracellular domain of human Fas and the death domain of TNFR1, but not with the intracellular region of CD40, a closely related receptor that lacks a death domain ( Figure 1B ). The sequence C-terminal to the Fas death domain has been shown to inhibit the cytotoxicity of Fas death domain , and it also inhibits the binding of FADD to Fas (Chinnaiyan et al., 1995) . The presence of this inhibitory region had no effect on the binding of clone A21 to Fas because clone A21 interacted equally well with FasDD and FasIC (Figure 1B) .
We mapped the Fas interaction domain on clone A21 to its C-terminal 112 amino acids by deletion analysis ( Figure 1C ). This region showed no evident sequence similarity to death domains, suggesting that the interaction between clone A21 and Fas is not through a homotypic death domain association. contains two small proline-rich regions (Figure 2A ). and TNFR1 intracellular tail but not to immobilized GST, GST-CD40 intracellular tail, or GST-Fas lpr cg death domain ( Figure 3A ). Daxx migrated with an apparent molecular weight of approximately 120 kDa on SDS-PAGE; this slower than expected migration may reflect the high content of acidic residues in Daxx. In the GST pull-down assay,
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S-Daxx bound to GST-FasDD but only very weakly to GST-TNFR1. This discrepancy with the twohybrid result (Figure 1 ) may be due to the nonlinear readout of the two-hybrid system. Deletion of 162 amino acids from the C terminus of Daxx abrogated binding to GST-FasDD, while the C-terminal 112 amino acids (DaxxC) were sufficient to bind GST-FasDD ( Figure 3B) , consistent with the two-hybrid results.
To determine whether Daxx interacted with Fas in mammalian cells, human embryonic kidney 293 cells were cotransfected with constructs expressing hemag- GST-FasIC but not with GST using glutathione beads.
Positions of MW standards (in kDa) are shown at left. CoomassieAgain, this interaction was dependent on the C-terminus stained GST fusion proteins from the same gel were aligned to show of Daxx ( Figure 3C ). GST-FasIC was also able to copreprotein levels.
cipitate HA-tagged Fas death domain, confirming that are uncertain whether Daxx binds to the inactive Fas. Collectively, these data show that the C terminus of Daxx mediates an interaction between the Fas death domain and Daxx, and that this interaction is likely to occur directly and in vivo.
Daxx Potentiates Fas-Mediated Apoptosis
To study the role of Daxx in Fas signaling, we chose 293 cells and HeLa cells. Both are sensitive to Fasand TNF-mediated apoptosis, and their normally flat morphology facilitates the scoring of apoptotic cells, characterized by membrane blebbing, pyknosis, and cell body condensation ( Figure 4A ). Cells scored to be apoptotic by morphology also exhibited nuclear condensation and fragmentation as judged by Hoechst staining (data not shown). HeLa and 293 cells were transfected with various expression constructs and an expression construct for ␤-galactosidase; at defined times after the transfection, cells were stained for ␤-galactosidase activity to mark the transfected cells and scored for apoptotic morphology. In 293 cells, transient overexpression of Fas induced apoptosis in a dose-dependent shown). Overexpression of Daxx by itself did not induce may be a rate-limiting step downstream of receptor engagement.
In an analogous approach to assess the function of Daxx, we established murine fibroblast L929 cell lines that stably overexpressed Daxx (L/Daxx). L/Daxx cells are substantially more susceptible to Fas killing compared to vector-transfected cells (L/EBB). This stimulation effect appeared to be a kinetic one: compared to L/EBB, the L/Daxx culture had greater than 3-fold more apoptotic cells 24 hours after Fas transfection, but L/EBB cells caught up by 48 hours after transfection ( Figure 4D ). TNF-␣-, TNFR1-, or FADD-mediated apoptosis was not increased in L/Daxx cells ( Figure 4D and data not shown). Therefore, L/Daxx cells are not generally more sensitive to apoptosis, but are specifically sensitized to the Fas signal, suggesting that Daxx is a mediator of Fas-induced killing.
Daxx Activates the JNK/SAPK Pathway
The lack of death domain homology or constitutive cell death activity suggests that Daxx may play a different role from previously identified death domain-binding proteins in Fas signaling. Fas has been reported to activate the JNK pathway (Latinis and Koretzky, 1996; Goillot et al., 1997; Lenczowski et al., 1997) , which is required in certain cell lines for the analogous TNF-␣-induced apoptosis (Verheij et al., 1996) . We therefore analyzed the ability of Fas and Daxx to activate the kinase activity of JNK and JNK-dependent transcription. In transient transfection assays in 293 cells, Fas activated JNK-1, As an independent measure of JNK activity, we tested apoptosis, but Daxx coexpression significantly enthe ability of Fas and Daxx to stimulate signaling to SRF hanced Fas-mediated apoptosis ( Figure 4B ). Parallel ex-(Serum Response Factor). JNK can phosphorylate and periments with TNFR1 did not show any enhancement activate SRF independent of the MEK/MAPK pathway, of apoptosis by Daxx, consistent with the much lower and the level of JNK activation in vivo can be assayed affinity of Daxx for TNFR1 ( Figure 3A) . using a reporter gene driven by SRE-L, a derivative of In HeLa cells, transient transfection of Fas led to ro-SRE that specifically binds SRF . In 293 bust, dose-dependent, and saturable cell death (Figures cells, Fas induced SRF-dependent transcription about 4A and 4C), which was further enhanced by the addition 4-fold, and Daxx induced it about 6-fold. TNF-␣, a known of Jo2. As in 293 cells, overexpression of Daxx alone inducer of the JNK pathway, stimulated the SRFdid not induce apoptosis in HeLa cells. In the range reporter gene to a level similar to that induced by Fas where apoptosis was proportional to input Fas DNA, or Daxx ( Figure 5C ). coexpression of Daxx significantly increased Fas-mediCollectively, these data show that Daxx is an activator of the JNK pathway. ated apoptosis (Figure 4C ), suggesting that Daxx activity To further dissect Daxx signaling, we asked which reng/ml) was added 16 hr later. X-Gal staining was done 24 hr after transfection.
gions of Daxx were required for its three activities: Fas Deletion mutagenesis showed that DaxxC, the C-terminal 112 amino acids of Daxx, was necessary and suffia normally latent cell death activity. Because Daxx⌬C is unable to bind Fas death domain ( Figures 3B and 3C ), cient to bind Fas but more N-terminal domains were required to activate JNK and cell death. Thus, we tested this cell death activity is likely to be independent of Fas or other death domain proteins. Further deletions whether DaxxC can act as a dominant-negative inhibitor of endogenous Daxx by competing with its binding to revealed that a peptide containing amino acids 501-625, which lies immediately N-terminal to the Fas-binding Fas. We chose to use HeLa cells in these experiments because the cells have a robust response to transfected domain, contained most of the cell death activity (Figure 6A) .
Fas ( Figure 4C ) and are the source of clone A21 from the two-hybrid screen. In Figure 6B , we show that exWhen these Daxx mutants were tested for their ability to activate JNK, we observed that each deletion mutant pression of DaxxC gave a dose-dependent suppression of Fas-mediated apoptosis. Fas-induced c-Jun phosmaintained some level of JNK activity with the exception of DaxxC; the majority of the activity came from just the phorylation was also inhibited by DaxxC in HeLa cells (data not shown) and in 293 cells ( Figure 6C ). To address region with amino acids 501-625 ( Figure 6A ). This result suggests that JNK activation may be involved in Daxxthe specificity of DaxxC, we then coexpressed fulllength Daxx with DaxxC and asked if this combination stimulated apoptosis. However, full-length Daxx activates JNK but does not cause constitutive apoptosis, now reversed the dominant-negative effect. If DaxxC ( Figure 6 ) and suggest that Daxx and FADD bind independently to Fas and activate distinct pathways. Consistent with this interpretation, FADD-induced cell death is not blocked by DaxxC ( Figure 7C ). In addition, DaxxC plus FADD(80-205) inhibited Fas-induced cell death substantially more than saturating amounts of either dominant-negative protein alone ( Figure 7A, lanes 7) . Thus, Daxx and FADD activate apoptosis downstream of Fas by distinct but cooperative pathways. Fas-mediated apoptosis can be inhibited by crmA and, in some cell types, by Bcl-2, a negative regulator of cell death Enari et al., 1995; Los et al., 1995; Tewari and Dixit, 1995; Lacronique et. al., 1996) . To dissect the apoptotic pathways initiated by overexpression of Fas, Daxx, and FADD, we tested the ability of crmA, Bcl-2, SEK(AL), and TAM67 to block each apoptotic inducer. SEK(AL) and TAM67 are dominant-negative inhibitors of the JNK pathway. SEK1 is the kinase that phosphorylates and activates JNK; SEK(AL) encodes a mutant that has a single mutation at the ATPbinding site, abrogating the kinase activity (Sanchez et al., 1994) . TAM67 is a variant of c-Jun in which amino acids 3-122 have been deleted. This mutant can dimerize and bind DNA but lacks a transcriptional activation found that Fas-induced apoptosis in L929, 293, and Jo2 (12.5 ng/ml) was added 16 hr later; X-Gal staining was done 24
HeLa cells can be blocked by crmA and Bcl-2-type inhib- Kolesnick and colleagues have reported that TNF-␣-induced apoptosis is inhibited in U937 human monoblastic leukemia cells that stably express TAM67 (Verheij were binding other death domain-containing proteins et al., 1996); these cells are also resistant to Fas-medi-(e.g., FADD), coexpression of full-length Daxx would ated apoptosis (data not shown). Taken together, these further titrate FADD away from Fas and inhibit apoptosis.
observations indicate that the requirement for the JNK Instead, coexpression of Daxx with Fas and DaxxC gave pathway in Fas-mediated apoptosis is cell-type specific. a dose-dependent rescue of Fas-induced apoptosis We note that this type of dominant-negative experiment ( Figure 6B ). This result argues that the only functions gives a positive result only if the protein in question is made deficient by DaxxC are those of intact Daxx, imuniquely required for a particular process. In a case plying that DaxxC specifically competes with endogewhere a negative result (no inhibition) is obtained, it nous Daxx but not other proteins for binding to Fas.
may be that the protein in question is involved but is These results suggest that endogenous Daxx is required functionally redundant or in great excess. The continued for Fas-induced apoptosis and JNK activation. discovery of JNK relatives makes such scenarios plausible (Gupta et al., 1996) .
Daxx and FADD Define Two Distinct
Next, we tested the same panel of inhibitor genes on Fas-Mediated Signaling Pathways FADD-and Daxx-induced apoptosis. Since full-length Because Daxx and FADD are both required for FasDaxx does not induce apoptosis by itself, we used induced apoptosis, we assessed how these two effectwo alternative strategies: we examined the apoptotic tors may be related to each other by a dominant-negaresponse of Fas plus Daxx in 293 cells (where a large tive approach. The FADD death domain, , fraction of the apoptotic response is Daxx dependent, has been shown to block Fas-induced death presum- Figure 4B ) and the apoptotic response of Daxx 501-625, ably by preventing the binding of endogenous FADD the smallest domain that has constitutive cell death (Chinnaiyan et al., 1996) . We found that activity in 293 cells ( Figure 6A ). Daxx-dependent partially inhibited Fas-induced death ( Figure 7A , lanes apoptosis was blocked by crmA and Bcl-2 and required 1-3) but did not inhibit JNK activation ( Figure 7B ). Morethe JNK pathway, which paralleled the inhibition profile over, the effect of FADD(80-205) on cell death was not of Fas in 293 cells ( Figure 8B ). In contrast, FADD, which reversed by coexpression of excess Daxx ( Figure 7A, can not activate JNK, was inhibited only by crmA, but not by Bcl-2, SEK(AL), or TAM67. Similarly, Hsu et al. lane 4). These results contrast with the effects of DaxxC activate the JNK pathway ( Figure 5 ; Latinis and Koretzky, 1996; Goillot et al., 1997; Lenczowski et al., 1997) . JNK activation is unlikely to be secondary to apoptosis because it is not inhibited by blocking the apoptotic caspases ( Figure 5A ). The fact that FADD induces cell death but not JNK activation provides powerful evidence that Fas must engage additional signaling molecules to activate JNK. While RIP and TRAF2 are recruited by TNFR1 to activate JNK, currently no known Fas effector can account for its JNK activation. In this study, Daxx emerges as the missing link between Fas and the JNK pathway. Daxx directly binds to the death domain of Fas, and overexpression of Daxx or its effector domain is sufficient to activate the JNK pathway. In addition, a specific dominant-negative inhibitor of Daxx blocks Fasinduced JNK activation. The JNK pathway is activated by many stress stimuli (such as oxidative damage, irradiation, and ischemia-reperfusion) that culminate in apoptosis (Verheij et al., 1996) , but the signaling events upstream of the kinase cascades are poorly understood. Daxx may have general importance in coupling other death signals to JNK, and its effector domain should be a useful probe for uncovering the molecular connections that lead to JNK activation.
It is becoming increasingly clear that activation of the an important role for the modulation of gene expression during apoptosis. However, the involvement of the JNK pathway in have shown that TRADD-mediated apoptosis is not apoptosis is commonly analyzed by dominant-negative blocked by Bcl-2 . Consistent with the proteins and may be complicated by several factors. For two pathway model, the residual Fas-induced death reexample, Fas-mediated apoptosis has been reported to maining after either DaxxC or FADD(80-205) treatment not involve JNK in Jurkat cells (Lenczowski et al., 1997 ) are qualitatively different: the apoptosis remaining after but to require JNK in SHEP cells (Goillot et al., 1997) . FADD(80-205) treatment is Bcl-2 sensitive, but the These results may reflect a cell-type-dependent variaapoptosis remaining after DaxxC treatment is not ( Figure  tion of the relative contribution of Daxx and FADD path-7A, lanes 8 and 9). Our results suggest that Fas activates ways. Alternatively, a negative result may reflect the two distinct cell death pathways-one via FADD that is functional redundancy of kinase isoforms in the MAP Bcl-2 insensitive and a second one via Daxx that actikinase cascades that make up the JNK and p38/Mpk2 vates JNK and is Bcl-2 sensitive.
pathways. Another possibility is that various tissue culture cell lines are originally derived from different tumors, Discussion and oncogenes, such as Ha-Ras, are known to activate the JNK pathway (Hibi et al., 1993; Derijard et al., 1994) ,
Daxx Is the Missing Link between Fas
giving different basal JNK activity in different cell lines.
and the JNK Pathway
As the most receptor-proximal protein leading to JNK The Fas-FADD-FLICE connection is currently the best activation, Daxx may be an experimentally tractable tarunderstood model for apoptotic signal transduction get for dissecting the contribution of JNK signals to Fas-(Fraser and Evan, 1996; Nagata, 1997) structural analysis of the Fas death domain suggest that this mutant may be unfolded and is thus uninformative
Plasmid Construction
for mapping the exact site of binding (Huang et al., 1996) .
DNA fragments for most plasmid constructs were obtained by PCR amplification using Pfu polymerase (Stratagene) and primers incorHowever, Daxx has no evident death domain and inter- in vivo. Daxx and FADD not only appear to bind differently to Fas but transduce physiologically distinct death signals.
Two-Hybrid Screen and ␤-Galactosidase Assay
The two-hybrid screen was performed essentially as described (Gy- As summarized by the model in Figure 8C , FADD directly uris et al., 1993) . Among 1 ϫ 10the Fas death signal to be regulated by Bcl-2.
Experimental Procedures
In Vitro Binding and Coprecipitation Assays GST fusions were purified as described (Smith and Johnson, 1988) .
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S-proteins were made with TNT Reticulocyte Lysate System (ProReagents and Cell Lines Anti-murine Fas Jo2 antibody was the generous gift of S. Nagata mega).
S-proteins were incubated with 10 g of each GST fusion protein in 0.1 ml of modified E1A buffer with 50 (Ogasawara et al., 1993 
